Long-Term Adherence to Evidence Based Secondary Prevention Therapies after Acute Myocardial Infarction

被引：0
|
作者：
Ayse Akincigil
John R. Bowblis
Carrie Levin
Saira Jan
Minalkumar Patel
Stephen Crystal
机构：
[1] Rutgers,School of Social Work
[2] The State University of New Jersey,Center for Health Services Research on Pharmacotherapy, Chronic Disease Management, and Outcomes, Institute for Health, Health Care Policy and Aging Research
[3] Rutgers,Ernest Mario School of Pharmacy
[4] The State University of New Jersey,undefined
[5] Rutgers University,undefined
[6] Horizon Blue Cross Blue Shield of New Jersey,undefined
[7] Horizon Healthcare Insurance Company of New York,undefined
来源：
Journal of General Internal Medicine | 2008年 / 23卷
关键词：
acute myocardial infarction; adherence; beta-blockers; angiotensin converting enzyme inhibitors (ACEI); secondary prevention;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：115 / 121
页数：6
相关论文
共 50 条
  • [21] Evidence-based secondary prevention after myocardial infarction
    De Backer, G
    ACTA CLINICA BELGICA, 1999, 54 (05) : 293 - 298
  • [22] Long-term adherence to evidence-based secondary prevention in coronary artery disease
    Newby, LK
    LaPointe, NMA
    Kramer, JM
    Chen, A
    Hammil, BG
    Muhlbaier, LH
    DeLong, ER
    Califf, RM
    CIRCULATION, 2004, 109 (20) : E231 - E231
  • [23] Long term adherence to evidence-based cardioprotective medications after acute myocardial infarction and its impact on mortality
    Hamood, H.
    Hamood, R.
    Almog, R.
    EUROPEAN HEART JOURNAL, 2015, 36 : 1151 - 1152
  • [24] Smartphone apps and secondary prevention after myocardial infarction - Howcan long-term usage be improved?
    Cheng, Kevin
    Oswal, Abhishek
    AMERICAN HEART JOURNAL, 2017, 184
  • [25] Long-term continuation to pharmacological treatment for secondary prevention after a myocardial infarction: a register study
    Sakalaki, M. S.
    Pivodic, A. P.
    Rosengren, A. R.
    Fu, M. F.
    Bjorck, L. B.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [26] Adherence to Long-Term Therapies Evidence for Action
    Shankar, P. R.
    Subish, P.
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2007, 1 (05) : 452 - 453
  • [27] Long-term continuation to pharmacological treatment for secondary prevention after a myocardial infarction: a register study
    Sakalaki, M. S.
    Pivodic, A. P.
    Rosengren, A. R.
    Fu, M. F.
    Bjorck, L. B.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [28] Adherence to long-term therapies:: Evidence for action
    Burkhart, PV
    Sabaté, E
    JOURNAL OF NURSING SCHOLARSHIP, 2003, 35 (03) : 207 - 207
  • [29] Lipoprotein(a) and Long-Term Recurrent Infarction After an Acute Myocardial Infarction
    Minana, Gema
    Cordero, Alberto
    Facila, Lorenzo
    Company, Mireia
    Fernandez-Cisnal, Agustin
    Valero, Ernesto
    Carratala, Arturo
    Navarro, Jorge
    Llergo, Javier Torres
    Fernandez-Olmo, Rosa
    Castro, Almudena
    Bodi, Vicent
    Sanchis, Juan
    Nunez, Julio
    AMERICAN JOURNAL OF CARDIOLOGY, 2024, 211 : 9 - 16
  • [30] Response to letter regarding article, "Long-term adherence to evidence-based secondary prevention therapies in coronary artery disease"
    Newby, L. Kristin
    Allen-LaPointe, Nancy M.
    Chen, Anita Y.
    Kramer, Judith M.
    Hammill, Bradley G.
    DeLong, Elizabeth R.
    Muhlbaier, Lawrence H.
    Califf, Robert M.
    CIRCULATION, 2006, 114 (06) : E241 - E241
12345